{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:18:27Z","timestamp":1769854707101,"version":"3.49.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Cancer Center Support","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}]},{"DOI":"10.13039\/100005625","name":"RSNA Research & Education Foundation","doi-asserted-by":"publisher","award":["RR2111"],"award-info":[{"award-number":["RR2111"]}],"id":[{"id":"10.13039\/100005625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"DOD","doi-asserted-by":"publisher","award":["W81XWH-21-1-0709"],"award-info":[{"award-number":["W81XWH-21-1-0709"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA210181"],"award-info":[{"award-number":["U54CA210181"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA143837"],"award-info":[{"award-number":["U54CA143837"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA196403"],"award-info":[{"award-number":["U01CA196403"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA200468"],"award-info":[{"award-number":["U01CA200468"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA200468"],"award-info":[{"award-number":["U01CA200468"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA214263"],"award-info":[{"award-number":["U01CA214263"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50CA221707"],"award-info":[{"award-number":["P50CA221707"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA221971"],"award-info":[{"award-number":["R01CA221971"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA218004"],"award-info":[{"award-number":["R01CA218004"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Limited data from small series have suggested that brain metastases from biliary tract cancers (BrM-BTC) affect \u22642% of patients with BTC. We sought to review our experience with patients with BrM-BTC and to identify associations of tumor-related molecular alterations with outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A retrospective review of patients with BTC seen at a tertiary referral center from 2005 to 2021 was performed; patients with BrM-BTC were identified, and clinical and molecular data were collected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-one of 823 patients with BTC (2.6%) developed BrM. For patients with BrM-BTC, median follow-up time was 27.9 months after primary BTC diagnosis and 3.1 months after BrM diagnosis. Median time from primary diagnosis to diagnosis of BrM was 14.4 [range, 1.1-66.0] months. Median overall survival (OS) from primary diagnosis was 31.5 [2.9-99.8] months and median OS from BrM diagnosis was 4.2 [0.2-33.8] months. Patients who underwent BrM-directed therapy trended toward longer OS following BrM diagnosis than patients receiving supportive care only (median 6.5 vs 0.8 months, P = .060). The BrM-BTC cohort was enriched for BRAF (30%), PIK3CA (25%), and GNAS (20%) mutations. patients with BrM-BTC with BRAF mutations trended toward longer OS following BrM diagnosis (median 13.1 vs 4.2 months, P = .131).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This is the largest series of patients with BrM-BTC to date and provides molecular characterization of this rare subgroup of patients with BTC. Patients with BrM-BTC may be more likely to have BRAF mutations. With advances in targeted therapy for patients with BTC with actionable mutations, continued examination of shifting patterns of failure, with emphasis on BrM, is warranted.<\/jats:p><\/jats:sec>","DOI":"10.1093\/oncolo\/oyac273","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T11:34:18Z","timestamp":1675078458000},"page":"327-332","source":"Crossref","is-referenced-by-count":4,"title":["Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis"],"prefix":"10.1093","volume":"28","author":[{"given":"Grace N","family":"Dodoo","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"},{"name":"Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3468-3359","authenticated-orcid":false,"given":"Brian","family":"De","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"},{"name":"Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunyoung S","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Abi Jaoude","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"},{"name":"Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4921-5427","authenticated-orcid":false,"given":"Jean-Nicolas","family":"Vauthey","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6035-7288","authenticated-orcid":false,"given":"Ching-Wei D","family":"Tzeng","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hop S","family":"Tran Cao","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalman A","family":"Katlowitz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine , Houston, TX , USA"},{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob J","family":"Mandel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas H","family":"Beckham","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D","family":"Minsky","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3171-2911","authenticated-orcid":false,"given":"Grace L","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma B","family":"Holliday","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert C","family":"Koong","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cullen M","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milind","family":"Javle","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-3461","authenticated-orcid":false,"given":"Eugene J","family":"Koay","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-5344","authenticated-orcid":false,"given":"Ethan B","family":"Ludmir","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"},{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center , Houston, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"issue":"10272","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet."},{"key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/CMAR.S157156","article-title":"Biliary tract cancer: current challenges and future prospects","volume":"11","author":"Ghidini","year":"2019","journal-title":"Cancer Manag Res"},{"key":"2023040615571334200_","year":"6\/16\/2022"},{"issue":"8","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12082039","article-title":"Targeted therapies in advanced biliary tract cancer: an evolving paradigm","volume":"12","author":"Chakrabarti","year":"2020","journal-title":"Cancers (Basel)."},{"issue":"1","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000479929","article-title":"Brain metastases from biliary tract cancer: a monocentric retrospective analysis of 450 patients","volume":"94","author":"Frega","year":"2018","journal-title":"Oncology."},{"issue":"5","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1634\/theoncologist.2019-0306","article-title":"Brain metastases from biliary tract cancers: a case series and review of the literature in the genomic era","volume":"25","author":"D\u2019Andrea","year":"2020","journal-title":"Oncologist."},{"issue":"5","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.7314\/APJCP.2012.13.5.1995","article-title":"Brain metastases from cholangiocarcinoma: a first case series in Thailand","volume":"13","author":"Chindaprasirt","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"822","DOI":"10.21037\/jgo-21-818","article-title":"Biliary cancer brain metastases: a multi-institution case series with case reports","volume":"13","author":"Falkson","year":"2022","journal-title":"J Gastrointest Oncol."},{"issue":"9","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","article-title":"New horizons for precision medicine in biliary tract cancers","volume":"7","author":"Valle","year":"2017","journal-title":"Cancer Discov."},{"issue":"5","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"issue":"9","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-020-01330-y","article-title":"Pemigatinib: first approval","volume":"80","author":"Hoy","year":"2020","journal-title":"Drugs"},{"issue":"13","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1158\/1078-0432.CCR-21-4462","article-title":"FDA approval summary: ivosidenib for the treatment of patients with advanced unresectable or metastatic, chemotherapy refractory cholangiocarcinoma with an IDH1 mutation","volume":"28","author":"Casak","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1470-2045(20)30321-1","article-title":"Dabrafenib plus trametinib in patients with &lt;em&gt;BRAF&lt;\/em&gt;V600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial","volume":"21","author":"Subbiah","year":"2020","journal-title":"Lancet Oncol"},{"key":"2023040615571334200_","year":"2022"},{"issue":"3","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/cncr.32547","article-title":"Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: a case series","volume":"126","author":"Holbrook","year":"2020","journal-title":"Cancer."},{"issue":"9992","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","article-title":"Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial","volume":"386","author":"Long","year":"2015","journal-title":"Lancet."},{"issue":"1","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S1470-2045(16)30122-X","article-title":"Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial","volume":"17","author":"Ascierto","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1470-2045(18)30142-6","article-title":"Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial","volume":"19","author":"Dummer","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5","key":"2023040615571334200_","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/28\/4\/327\/49789428\/oyac273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/28\/4\/327\/49789428\/oyac273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T03:32:18Z","timestamp":1701574338000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/28\/4\/327\/7008897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,1,28]]},"published-print":{"date-parts":[[2023,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyac273","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2023,1,28]]}}}